i see oncs has 130 million shares. it think oncs has the potential to be a major carpet bagger in the long term. i mean im not totally impressed by the animal studies since this is fairly common, BUT that doesnt mean the market wont react to it in a positive way.
my concern is oncs will need an RS to get listed on nasdaq/amex/nyse, which would negatively affect longs. i know i know it doesnt necessarily change the value of your shares, but in biotech an rs almost ALWAYS leads to a drop in pps, often 20-30%.
the way i see it oncs needs a partnership by end of next year right? or it will have to dilute some more? i want to make oncs my major long stock. like 20-30,000 shares, but the management concerns me. looking at the hope page of the CEO and it is just....shady. very very hollywood, im afraid they r holding something back.
Wow, the first intelligent post that I have seen here. Yes, this stock will RS eventually. They will do this to raise the stock price up, reducing the number of shares floated and appear more attractive to a financial partner. Can you imagine owning 50,000 shares of this company to find out the next day that you only now own 6,000 after a reverse 8:1 ? But, how long will your 6,000 shares stay at $2.00 after the RS 8:1 @ .25 ? Not long, because this is when the real strong shorts jump on board & bring it back down to sub $1.00. Then, you will have lost 50% of your investment in a blink of an eye. get out now.
it's OTC company...OTC does not do a reverse split. If it's NASDAQ, then they do it...don't worry about it...If they need money, then they will sell out their SHARES such as PUBLIC OFFERING..BLAHH BLAHH